Press release
Transformative Trends Impacting the Darbepoetin Alfa (Aranesp) Market Landscape: Oral Darbepoetin Alfa Alternative Fuels Innovation In Chronic Anemia Treatment
Darbepoetin Alfa (Aranesp)
How Large Will the Darbepoetin Alfa (Aranesp) Market Size By 2025?
In recent times, there has been a robust growth in the market size of darbepoetin alfa (aranesp). The market is expected to swell from $5.81 billion in 2024 to about $6.11 billion by 2025, marking a compound annual growth rate (CAGR) of 5.2%. This trend in the historic period is attributable to advancements in anemia treatment, an increased demand for erythropoiesis-stimulating agents (ESAs), innovation in the biopharmaceutical sector, acceptance in clinical practices, and better patient outcomes.
How Big Is the Darbepoetin Alfa (Aranesp) Market Size Expected to Grow by 2029?
The market for darbepoetin alfa (aranesp) is anticipated to experience robust expansion in the coming years. It is forecasted to surge to $7.51 billion by 2029, with a compound annual growth rate (CAGR) of 5.3%. This projected growth in the forecast period is due to factors such as healthcare reimbursement policies, enhanced awareness and education, development of healthcare infrastructure, the need for renal care, and an aging population. Key trends shaping this forecast period encompass global market penetration, the incorporation of digital health, personalized treatment strategies, adoption of biosimilars, and the use of long-acting formulations.
View the full report here:
https://www.thebusinessresearchcompany.com/report/darbepoetin-alfa-aranesp-global-market-report
Which Key Market Drivers Powering Darbepoetin Alfa (Aranesp) Market Expansion and Growth?
The surge in chronic diseases is anticipated to fuel the expansion of the darbepoetin alfa market. Chronic diseases, which are illnesses that persist for over three months and could worsen over time, are treated using darbepoetin alfa. This medication also counteracts anemia caused by chemotherapy in cancer patients. For example, data from the Australian Institute of Health and Welfare, an Australian Government statutory authority, revealed that chronic conditions accounted for 171,500 deaths in 2022, making 90% of all deaths, at a rate of 659 per 100,000 population. While the age-standardised death rate because of such conditions declined to 448 per 100,000 in 2020, it then rose to 459 in 2021 and 490 in 2022. Consequently, the escalating prevalence of chronic diseases is contributing to the rise of the darbepoetin alfa market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12171&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Darbepoetin Alfa (Aranesp) Market?
Innovations in product development are emerging as a significant trend in the darbepoetin alfa market. Major players in this market are embracing new technologies to maintain their market positioning. One such example is GlaxoSmithKline. Ltd., a UK-based pharma and biotech firm. In February 2023, the company launched a novel product named Jesduvroq (daprodustat), which was approved by the US FDA. Daprodustat also known as recombinant human erythropoietin (rhEPO, darbepoetin alfa, or epoetin alfa) is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor. It is intended to be used daily for treating anemia in individuals suffering from chronic kidney disease (CKD), specifically those who have been undergoing dialysis for a minimum of four months.
What Are the Emerging Segments in the Darbepoetin Alfa (Aranesp) Market?
The darbepoetin alfa (aranesp) market covered in this report is segmented -
1) By Type: Epogen, Procrit, Aranesp, Other Types
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Patients With Chronic Kidney Disease, Patients With Cancer, Other Applications
Subsegments:
1) By Epogen: Standard Formulations, Enhanced Formulations
2) By Procrit: Standard Formulations, Biosimilars
3) By Aranesp: Single-Dose Vials, Multi-Dose Vials
4) By Other Types: Combination Therapies, Alternative Erythropoiesis-Stimulating Agents
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12171&type=smp
Who Are the Global Leaders in the Darbepoetin Alfa (Aranesp) Market?
Major companies operating in the darbepoetin alfa (aranesp) market include Johnson & Johnson, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Biocon Ltd., Reliance Life Sciences, Torrent Pharmaceuticals Ltd., 3SBio Inc., Cadila Healthcare Ltd., Dong-A ST Co. Ltd., Chong Kun Dang Holdings, Hetero Drugs Ltd., Intas Pharmaceuticals Ltd., Avesthagen Pharma, Stada Arzneimittel AG, Ranbaxy Laboratories Ltd., Sandoz International GmbH, Shandong Kexing Bioproducts Co. Ltd., Kyowa Kirin Co. Ltd., Polifarma S.p.A.
Which are the Top Profitable Regional Markets for the Darbepoetin Alfa (Aranesp) Industry?
North America was the largest region in the darbepoetin alfa (Aranesp) market in 2024. The regions covered in the darbepoetin alfa (Aranesp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12171
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transformative Trends Impacting the Darbepoetin Alfa (Aranesp) Market Landscape: Oral Darbepoetin Alfa Alternative Fuels Innovation In Chronic Anemia Treatment here
News-ID: 4099771 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Aranesp
Key Players and Competitive Dynamics in the Darbepoetin Alfa (Aranesp) Market
The darbepoetin alfa (Aranesp) market is poised for substantial growth as healthcare advancements and patient needs continue to evolve worldwide. With increasing awareness, improved healthcare infrastructure, and an aging population, this market is attracting significant attention. Let's explore the current market size, key players, emerging trends, and the main segments shaping this sector's future.
Projected Growth and Market Size of the Darbepoetin Alfa (Aranesp) Market
The darbepoetin alfa (Aranesp) market…
Global Darbepoetin Alfa (Aranesp) Market Projected to Grow at 5% CAGR, Reaching …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Darbepoetin Alfa (Aranesp) Industry Market Size Be by 2025?
In recent years, there has been a consistent expansion of the darbepoetin alfa (aranesp) market. It's projected to increase from $5.81 billion in 2024 to $6.06 billion in 2025, boasting a compound annual growth rate (CAGR) of…
Darbepoetin Alfa (Aranesp) Market Size Forecasted To Achieve $7.51 Billion By 20 …
The Darbepoetin Alfa (Aranesp) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Darbepoetin Alfa (Aranesp) Market Size and Projected Growth Rate?
The Darbepoetin Alfa (Aranesp) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to…
Darbepoetin Alfa (Aranesp) Market Forecast 2025-2034: Evaluating Growth Factors, …
How Are the key drivers contributing to the expansion of the darbepoetin alfa (aranesp) market?
Expectations are bullish for the darbepoetin alfa market due to a projected surge in chronic disease cases. Chronic diseases, which are illnesses that persist for at least three months and can worsen over time, can be treated using darbepoetin alfa. This medication is especially useful for managing chemotherapy-induced anemia in cancer patients. As per data from…
Darbepoetin Alfa (Aranesp) Market Trends & Growth Forecast 2024-2033
The Business Research Company recently released a comprehensive report on the Global Darbepoetin Alfa (Aranesp) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Healing Innovation: Darbepoetin Alfa (Aranesp) Market Metrics Explore Size, Dema …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through Darbepoetin Alfa Aranesp Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The darbepoetin alfa (aranesp) market size has grown strongly in recent…
